Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-25
2005-01-25
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S211040, C514S211110, C540S455000, C540S461000, C540S488000, C540S522000
Reexamination Certificate
active
06846814
ABSTRACT:
Compounds having the general formulawherein R1a, R1b, R1c, R2, R3, R4, R5, R6, R7, R8, X1, X2, Y, Z and n are as defined in the specification, methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds.
REFERENCES:
patent: WO 9628158 (1996-09-01), None
patent: WO 0002859 (2000-01-01), None
patent: WO 0020003 (2000-04-01), None
patent: WO 0020389 (2000-04-01), None
patent: WO 0034243 (2000-06-01), None
patent: WO 0064423 (2000-11-01), None
Swain, C. et al, Ann. Reports Med. Chem., vol. 34, 1999, pp. 51-60.*
Asianian R. et al, Ann. Reports Med. Chem., vol. 36, 2001, pp. 31-40.
Albert Jeffrey Scott
Bernstein Peter
Ohnmacht, Jr. Cyrus
Russell Keith
Shenvi Ashokkumar Bhikkappa
Astra Zeneca AB
McKenzie Thomas C.
Mitchell Kenneth F.
LandOfFree
Neurokinin antagonists for use as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurokinin antagonists for use as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurokinin antagonists for use as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3406414